Please login to the form below

Not currently logged in
Email:
Password:

Matt de Gruchy to lead Ogilvy

Ogilvy Healthworld UK has appointed Matt de Gruchy as CEO with immediate effect

Ogilvy Healthworld UK has appointed Matt de Gruchy as CEO with immediate effect. He assumes responsibility for the continued growth of the company and succeeds Lois Hall who has led the company for two years.

Gloria Gibbons, president EMEA, AP, Latina of Ogilvy CommonHealth Worldwide said: "Matt has a proven track record of building business and providing exceptional client service. I'm certain he will bring the same focus on quality and success to his new role. Matt has the vision and experience to successfully navigate clients through rapidly evolving healthcare and communications environments."

De Gruchy has worked for Ogilvy Healthworld for 14 years and most recently held the roles of group director of client services and managing director of public relations.

Hall has been appointed to global planning director for Ogilvy Healthworld while continuing to provide senior level client counsel on key international accounts.  

Gibbons said of Hall: "Lois has done a fantastic job in leading the Ogilvy Healthworld UK business over the last two years and delivering a great performance as a key global hub in our network. Lois is renowned throughout the industry as a thought leader in healthcare communications and we are delighted that she will grow our strategic and consultancy-led offer in her new remit."

In addition to the restructure of the leadership of Ogilvy Healthworld UK, Antonia Betts, head of public relations and Tracey Wood, head of medical education are promoted to join the Ogilvy Healthworld UK board.

25th January 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...